Raymond James Financial’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-66,812
Closed -$978K 5296
2025
Q3
$978K Buy
66,812
+1,000
+2% +$13.1K ﹤0.01% 3687
2025
Q2
$734K Buy
65,812
+8,848
+16% +$110K ﹤0.01% 3766
2025
Q1
$929K Sell
56,964
-460
-0.8% -$8.07K ﹤0.01% 3550
2024
Q4
$1M Buy
+57,424
New +$998K ﹤0.01% 3447

Other funds holding OFIX

Raymond James Financial's OFIX Position: Q4 2025 in Review

Raymond James Financial sold out of Orthofix Medical (OFIX) in Q4 2025, closing a stake of 66,812 shares — an estimated $978K sold.

Raymond James Financial first reported a position in OFIX in Q4 2024 and held it in 4 quarters. The position peaked at $1M in Q4 2024. 143 funds tracked by Wall St. Rank hold OFIX as of Q4 2025.

  • Raymond James Financial reported no remaining Orthofix Medical position as of Q4 2025 after selling out during the quarter.
  • Raymond James Financial sold 66,812 Orthofix Medical shares in Q4 2025, an estimated $978K.
  • Raymond James Financial first reported a position in Orthofix Medical in Q4 2024 and held it in 4 quarters.
  • Raymond James Financial's Orthofix Medical position peaked at $1M in Q4 2024.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2025.

Based on Raymond James Financial's 13F filing for Q4 2025, filed 18 Feb 2026.